Zobrazeno 1 - 10
of 166
pro vyhledávání: '"N. M. Bleehen"'
Summary Background Many patients with small cell lung cancer are reported to lose weight, but the mechanism of this effect is unclear. Patients and methods Measurements of resting energy expenditure (REE), using indirect calorimetry and body composit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9806cf0ea388c3e06def61946690107c
https://ora.ox.ac.uk/objects/uuid:3870dbf3-5a88-427c-add5-b4f4eef71acc
https://ora.ox.ac.uk/objects/uuid:3870dbf3-5a88-427c-add5-b4f4eef71acc
Autor:
R. Arriagada, J. R. Bertino, N. M. Bleehen, O. Brodin, R. Feld, J. H. Goldie, H. H. Hansen, D. C. Ihde, T. Le Chevalier, R. L. Souhami, null and the Workshop Participants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c272c5638bb035a33707c3a7ae525c3
https://doi.org/10.1159/000416210
https://doi.org/10.1159/000416210
Autor:
P Beale, M A Macham, Julieann Sludden, A Rodriguez, J.S. de Bono, C Hutchison, N M Bleehen, Chris Twelves, I Dennis, C Gardner, P Vasey, A Flavin, Ian Judson
Publikováno v:
British Journal of Cancer. 80:1786-1791
Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II
Publikováno v:
British Journal of Cancer. 74:632-639
The role of post-operative radiotherapy for patients with non-small-cell lung cancer (NSCLC) is unclear despite five previous randomised trials. One deficiency with these trials was that they did not include adequate TNM staging, and so the present r
Autor:
Penelope Hopwood, N. M. Bleehen, G Lallemand, A.J. Bailey, Richard Stephens, David Machin, David J. Girling
Publikováno v:
British Journal of Cancer. 73:406-413
This randomised trial was conducted to compare a four-drug chemotherapy regimen as a control vs a less intensive two-drug regimen in terms of quality of life (QL), tumour response and survival in the palliative treatment of patients with small-cell l
Autor:
I F Dennis, D.J. Boote, M H Brampton, C Laburte, R J Osborne, S Hensel, John F. Smyth, N M Bleehen, P R Twentyman
Publikováno v:
Journal of Clinical Oncology. 14:610-618
PURPOSE To determine the maximum-tolerated dose (MTD) and toxicity of PSC 833 infusion administered with etoposide for 5 days in patients with cancer, and to determine the effect of PSC 833 on etoposide pharmacokinetics. PATIENTS AND METHODS Thirty-f
Autor:
Nicholas S. Reed, D.J. Radstone, A Lamont, N. M. Bleehen, David J. Girling, David Machin, Richard Stephens, F.R. Macbeth, T E Wheldon
Publikováno v:
Clinical Oncology. 8:176-181
Radiation myelopathy (RM) is an uncommon but serious late effect of thoracic radiotherapy (RT), which oncologists try to avoid by careful planning and dose selection. Five patients with RM are described from among 1048 with inoperable non-small cell
Autor:
F.R. Macbeth, David J. Girling, Richard Stephens, Penelope Hopwood, N. M. Bleehen, David Machin, J. J. Bolger, J. Cartmell, A.J. Bailey
Publikováno v:
Clinical Oncology. 8:167-175
In patients with non-metastatic but inoperable non-small cell lung cancer that is locally too extensive for radical radiotherapy (RT), but who have good performance status, it is important to determine whether thoracic RT should be the minimum that i
Publikováno v:
British Journal of Cancer
Nicotinamide and carbogen breathing are both effective radiosensitisers in experimental tumour models and are even more effective in combination. This study was to investigate the feasibility of using the agents in combination in patients and to meas